Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

1.1%

1 terminated/withdrawn out of 94 trials

Success Rate

98.6%

+12.1% vs industry average

Late-Stage Pipeline

27%

25 trials in Phase 3/4

Results Transparency

0 of 72 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1

46(49.5%)

Phase 3

21(22.6%)

Phase 2

12(12.9%)

N/A

10(10.8%)

Phase 4

4(4.3%)

93Total

Phase 1(46)

Phase 3(21)

Phase 2(12)

N/A(10)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (94)

Showing 20 of 94 trials

NCT06674265Phase 1Recruiting

Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

Role: collaborator

NCT06202547Phase 1Unknown

Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure

Role: lead

NCT06199024Not ApplicableRecruiting

Cinnamon and COH in PCOS Women Underdoing IVF/ICSI Cycles

Role: lead

NCT06199960Phase 3Completed

Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders

Role: lead

NCT04855383Not ApplicableCompleted

Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles

Role: lead

NCT03996837Not ApplicableCompleted

Platelet Rich Plasma and Recurrent Implantation Failure

Role: lead

NCT04672720Not ApplicableCompleted

L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles

Role: lead

NCT04013984Not ApplicableCompleted

Acupuncture for Treatment of Patients With Poor Ovarian Response

Role: lead

NCT04549649Not ApplicableCompleted

The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response

Role: lead

NCT04077970Phase 3Completed

Intrauterine Flushing With Follicular Fluid Plus Granulosa Cells

Role: lead

NCT04600986Not ApplicableCompleted

Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome

Role: lead

NCT03134690Not ApplicableCompleted

GnRh Antagonist Protocol With Delayed Start Stimulation in Patients With Poor Ovarian Response

Role: lead

NCT05460858Phase 3Unknown

NAC Effect on Infertile Women With Endometrioma

Role: lead

NCT05108012Phase 1Unknown

Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients

Role: lead

NCT02681029Phase 3Completed

The Clinical Outcomes Following Transfer of Blastocysts Cultured From Thawed Cleavage Stage Embryos

Role: lead

NCT03876145Not ApplicableCompleted

The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome

Role: lead

NCT03134157Phase 3Unknown

The Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Women

Role: lead

NCT02480127Not ApplicableCompleted

Molecular Evaluation of Endometrium After Endometrial Injury

Role: lead

NCT04366063Phase 2Unknown

Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome

Role: lead

NCT04078308Phase 1Unknown

Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients

Role: lead